Lisa K Stamp Selected Research

Allopurinol (Remid)

12/2022	Long-Term Follow-up of a Randomized Controlled Trial of Allopurinol Dose Escalation to Achieve Target Serum Urate in People With Gout.
1/2022	Allopurinol Initiation and All-Cause Mortality Among Patients With Gout and Concurrent Chronic Kidney Disease : A Population-Based Cohort Study.
1/2021	Efficacy and safety of urate-lowering therapy in people with kidney impairment: a GCAN-initiated literature review.
1/2020	Allopurinol hypersensitivity: Pathogenesis and prevention.
10/2019	Effects of Allopurinol Dose Escalation on Bone Erosion and Urate Volume in Gout: A Dual-Energy Computed Tomography Imaging Study Within a Randomized, Controlled Trial.
1/2019	Serum urate levels and therapy in adults treated with long-term dialysis: a retrospective cross-sectional study.
1/2019	Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!
12/2018	Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trial.
12/2018	ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol.
1/2018	How to prevent allopurinol hypersensitivity reactions?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa K Stamp Research Topics

Disease

113	Gout 12/2022 - 11/2009
34	Rheumatoid Arthritis 01/2022 - 04/2003
15	Inflammation (Inflammations) 01/2020 - 02/2004
11	Hyperuricemia 02/2021 - 11/2014
9	Arthritis (Polyarthritis) 02/2021 - 04/2003
9	Hypersensitivity (Allergy) 01/2020 - 08/2012
7	Chronic Renal Insufficiency 01/2022 - 01/2016
6	Pain (Aches) 01/2021 - 07/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2019 - 04/2003
4	Drug-Related Side Effects and Adverse Reactions 01/2018 - 03/2014
4	Rheumatic Diseases (Rheumatism) 02/2017 - 10/2011
3	Crystal Arthropathies 10/2022 - 12/2015
3	Infections 01/2022 - 11/2007
3	Osteoarthritis 01/2021 - 12/2017
3	Chronic Disease (Chronic Diseases) 01/2021 - 10/2016
3	Rheumatoid Nodule 01/2020 - 06/2008
3	Gouty Arthritis 01/2019 - 10/2015
3	Atherosclerosis 02/2016 - 11/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2016
2	Knee Osteoarthritis 01/2021 - 10/2015
2	Overweight 11/2020 - 01/2020
2	Genetic Risk Score 11/2020 - 01/2020
2	Heart Failure 10/2019 - 11/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 02/2016
2	Crohn Disease (Crohn's Disease) 01/2019 - 01/2018
2	Ankylosing Spondylitis 01/2018 - 10/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2016 - 01/2016
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 09/2010 - 04/2007
1	COVID-19 04/2022
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022
1	Urolithiasis 01/2021
1	Osteoporosis 01/2021
1	Kidney Calculi (Kidney Stone) 01/2021
1	Constipation 01/2021
1	Obesity 11/2020

Drug/Important Bio-Agent (IBA)

92	Uric Acid (Urate)IBA 12/2022 - 12/2010
35	Allopurinol (Remid)FDA LinkGeneric 12/2022 - 02/2011
11	Methotrexate (Mexate)FDA LinkGeneric 10/2019 - 10/2007
9	Pharmaceutical PreparationsIBA 04/2022 - 10/2007
7	Colchicine FDA LinkGeneric 04/2022 - 08/2011
7	Biomarkers (Surrogate Marker)IBA 12/2021 - 04/2003
7	Oxypurinol (Oxipurinol)IBA 12/2018 - 07/2013
6	DiureticsIBA 11/2020 - 09/2012
5	CreatinineIBA 01/2021 - 02/2011
5	Proteins (Proteins, Gene)FDA Link 12/2018 - 11/2013
5	Interleukin-17 (Interleukin 17)IBA 10/2012 - 02/2004
4	InterleukinsIBA 01/2020 - 11/2009
4	CytokinesIBA 01/2020 - 02/2004
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019 - 08/2011
4	InflammasomesIBA 01/2019 - 10/2015
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 08/2011
4	urate transporterIBA 01/2017 - 11/2009
4	methotrexate polyglutamateIBA 12/2011 - 11/2008
3	Calcium PyrophosphateIBA 10/2022 - 12/2015
3	Fish OilsIBA 06/2022 - 04/2003
3	Antirheumatic Agents (DMARD)IBA 01/2021 - 10/2007
3	Folic Acid (Vitamin M)FDA LinkGeneric 10/2019 - 06/2010
3	Biological ProductsIBA 10/2018 - 11/2013
3	HLA-B Antigens (HLA-B)IBA 01/2018 - 01/2015
3	ApolipoproteinsIBA 01/2017 - 11/2014
2	Interleukin-23 (Interleukin 23)IBA 01/2022 - 01/2012
2	GlucocorticoidsIBA 01/2022 - 10/2007
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 04/2007
2	BenzbromaroneIBA 01/2021 - 03/2014
2	Febuxostat FDA Link 01/2021 - 03/2014
2	Nortriptyline (Aventyl)FDA LinkGeneric 01/2021 - 10/2015
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021 - 01/2019
2	Pegloticase FDA Link 01/2021 - 01/2015
2	Infliximab (Remicade)FDA Link 01/2019 - 02/2005
2	EnzymesIBA 01/2019 - 07/2004
2	FructoseIBA 10/2017 - 09/2015
2	Organic Anion TransportersIBA 01/2017 - 01/2013
2	SugarsIBA 01/2017 - 12/2016
2	Furosemide (Lasix)FDA LinkGeneric 01/2017 - 09/2012
2	Triglycerides (Triacylglycerol)IBA 01/2016 - 11/2014
2	Peroxidase (Myeloperoxidase)IBA 11/2014 - 10/2012
2	AllantoinIBA 11/2014 - 04/2012
2	Polyglutamic Acid (Polyglutamate)IBA 03/2014 - 12/2011
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 10/2013 - 02/2005
2	RNA (Ribonucleic Acid)IBA 11/2009 - 06/2008
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2005 - 04/2003
1	micaIBA 10/2022
1	Fibrinogen (Factor I)FDA Link 11/2021
1	DNA Transposable Elements (Element, IS)IBA 02/2021
1	Probenecid (Benemid)FDA LinkGeneric 01/2021
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Diphosphonates (Bisphosphonates)IBA 01/2021
1	Inosine FDA Link 01/2021
1	lesinuradIBA 01/2021
1	ThiazidesIBA 11/2020
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 11/2020
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 11/2020
1	Interleukin-1 (Interleukin 1)IBA 01/2020
1	Interleukin-27 (Interleukin 27)IBA 01/2020
1	Anthocyanins (Anthocyanin)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020

Therapy/Procedure

42	Therapeutics 12/2022 - 02/2005
4	Biological Therapy 01/2020 - 01/2018
1	Plasma Exchange 01/2022